A detailed history of Beech Hill Advisors, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Beech Hill Advisors, Inc. holds 57,818 shares of EXAS stock, worth $3.43 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
57,818
Previous 59,647 3.07%
Holding current value
$3.43 Million
Previous $2.52 Million 56.19%
% of portfolio
1.54%
Previous 1.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$42.43 - $70.83 $77,604 - $129,548
-1,829 Reduced 3.07%
57,818 $3.94 Million
Q2 2024

Jul 12, 2024

BUY
$41.33 - $74.26 $327,994 - $589,327
7,936 Added 15.35%
59,647 $2.52 Million
Q1 2024

Apr 12, 2024

BUY
$56.27 - $73.77 $21,720 - $28,475
386 Added 0.75%
51,711 $3.57 Million
Q4 2023

Jan 10, 2024

BUY
$59.06 - $75.72 $97,153 - $124,559
1,645 Added 3.31%
51,325 $3.8 Million
Q3 2023

Oct 10, 2023

BUY
$65.94 - $99.04 $157,530 - $236,606
2,389 Added 5.05%
49,680 $3.39 Million
Q2 2023

Jul 10, 2023

SELL
$62.68 - $95.05 $133,195 - $201,981
-2,125 Reduced 4.3%
47,291 $4.44 Million
Q1 2023

Apr 14, 2023

SELL
$47.19 - $70.77 $70,313 - $105,447
-1,490 Reduced 2.93%
49,416 $3.35 Million
Q4 2022

Jan 17, 2023

SELL
$30.35 - $53.15 $483,627 - $846,945
-15,935 Reduced 23.84%
50,906 $0
Q3 2022

Oct 12, 2022

BUY
$31.97 - $49.37 $663,537 - $1.02 Million
20,755 Added 45.04%
66,841 $2.17 Million
Q2 2022

Jul 11, 2022

SELL
$35.61 - $76.23 $76,027 - $162,751
-2,135 Reduced 4.43%
46,086 $1.82 Million
Q1 2022

Apr 19, 2022

BUY
$57.56 - $82.54 $1.9 Million - $2.72 Million
32,930 Added 215.36%
48,221 $3.37 Million
Q4 2021

Jan 19, 2022

SELL
$72.5 - $100.68 $1.51 Million - $2.1 Million
-20,835 Reduced 57.67%
15,291 $1.19 Million
Q3 2021

Oct 14, 2021

BUY
$90.24 - $124.05 $262,147 - $360,365
2,905 Added 8.74%
36,126 $3.45 Million
Q2 2021

Jul 15, 2021

BUY
$93.66 - $139.27 $207,175 - $308,065
2,212 Added 7.13%
33,221 $4.13 Million
Q1 2021

Apr 19, 2021

BUY
$116.57 - $155.01 $99,550 - $132,378
854 Added 2.83%
31,009 $4.09 Million
Q4 2020

Jan 22, 2021

SELL
$99.61 - $142.12 $39,844 - $56,848
-400 Reduced 1.31%
30,155 $4 Million
Q3 2020

Oct 19, 2020

BUY
$72.92 - $102.01 $134,537 - $188,208
1,845 Added 6.43%
30,555 $3.12 Million
Q2 2020

Jul 17, 2020

BUY
$55.75 - $92.75 $9,756 - $16,231
175 Added 0.61%
28,710 $2.5 Million
Q1 2020

May 05, 2020

BUY
$37.9 - $104.44 $1.08 Million - $2.98 Million
28,535 New
28,535 $1.66 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Beech Hill Advisors, Inc. Portfolio

Follow Beech Hill Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beech Hill Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beech Hill Advisors, Inc. with notifications on news.